Overview

Study of Dose Adjustment From Levothyroxine to a New Levothyroxine Sodium Test Formulation

Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the effect of switching participants taking levothyroxine to a new sodium formulation.
Phase:
Phase 2
Details
Lead Sponsor:
Takeda